# GULA Healthcare Policy

**Version:** 1.0  
**Status:** RATIFIED  

---

## 1. Healthcare Philosophy

GULA is first and foremost a clinical platform. Every decision, every feature, every line of code must ultimately serve patient care. Clinical safety is not a feature — it is the foundation upon which everything else is built.

## 2. Clinical Safety Principles

### 2.1 Patient Safety First
No feature may compromise patient safety. If there is a conflict between business goals and patient safety, patient safety always wins.

### 2.2 Clinical Validation
All clinical algorithms must be validated against known standards before deployment. This includes:
- Reference ranges
- Critical values
- Clinical decision support rules
- Interpretation algorithms
- QC rules (Westgard, etc.)

### 2.3 Dual Verification
Critical results require dual verification:
- First verification by the testing technician
- Second verification by a senior technician or pathologist
- AI may suggest but never verify

### 2.4 Patient Identity
- Every clinical action requires positive patient identification
- Identity verification before sample collection
- Identity verification before result release
- Identity verification before clinical action

## 3. Clinical Terminology Standards

### 3.1 Required Standards

| Standard | Usage | Status |
|----------|-------|--------|
| LOINC | Laboratory test identification | Implemented |
| SNOMED CT | Clinical terminology | Implemented |
| ICD-10 | Diagnosis coding | Implemented |
| ICD-11 | Diagnosis coding (future) | Implemented |
| UCUM | Units of measure | Implemented |
| RxNorm | Medication terminology | Implemented |
| ATC | Anatomical-Therapeutic-Chemical | Implemented |
| CPT | Procedure coding | Implemented |

### 3.2 Terminology Governance
- All new lab tests must be mapped to LOINC codes
- All diagnoses must use ICD-10/11 codes
- All clinical findings must use SNOMED CT where applicable
- All units must use UCUM
- Terminology mappings must be versioned
- Terminology updates must be reviewed by Clinical Board

## 4. Interoperability Standards

### 4.1 Required Standards

| Standard | Status | Notes |
|----------|--------|-------|
| FHIR R4 | Implemented (mappers) | API server not yet deployed |
| HL7 v2.x | Implemented | For device integration |
| ASTM E1394 | Implemented | For device integration |
| DICOM | Planned | For radiology integration |
| IHE Profiles | Planned | XDS, PIX, PDQ |

### 4.2 FHIR Compliance (Target)
- All clinical resources must have FHIR R4 representations
- FHIR API must support: Patient, Observation, DiagnosticReport, ServiceRequest, Specimen
- FHIR search must support standard parameters
- FHIR operations must follow RESTful conventions
- SMART on FHIR for application launch context

## 5. Laboratory Standards

### 5.1 Specimen Lifecycle
Every specimen must follow a defined lifecycle with state enforcement:

```
Ordered → Collected → Received → In Progress → Analyzed → Validated → Reported → Archived
                                                                    → Rejected
                                                                    → QNS (Quantity Not Sufficient)
```

### 5.2 Quality Control
- Westgard rules must be evaluated on every QC run:
  - 1-2s (warning)
  - 1-3s (reject)
  - 2-2s (reject)
  - R-4s (reject)
  - 4-1s (reject)
  - 10x (reject)
- IQC (Internal Quality Control) with lot tracking
- EQA (External Quality Assessment) with Z-score evaluation
- QC data retention per regulatory requirements

### 5.3 Critical Value Management
- Critical values defined per test (low/high thresholds)
- Critical value alerts with acknowledgment workflow
- Escalation chain if critical value not acknowledged
- Audit trail for every critical value event

### 5.4 Chain of Custody
- Every specimen movement must be tracked
- Every aliquot must be traceable to parent specimen
- Every transfer must be signed off
- Temperature monitoring for cold chain compliance

## 6. Clinical Decision Support

### 6.1 CDS Types
| Type | Description | Implementation |
|------|-------------|---------------|
| Alerts | Critical value alerts, drug interactions | Implemented |
| Reminders | Preventive care, follow-up reminders | Models exist |
| Order Sets | Condition-specific order sets | Models exist |
| Care Bundles | Evidence-based care bundles | Models exist |
| Contraindications | Drug-disease/drug-drug | Models exist |
| Duplicate Detection | Duplicate order checking | Models exist |

### 6.2 CDS Governance
- All CDS rules must be approved by Clinical Board
- CDS rules must be evidence-based
- CDS rules must be versioned
- CDS effectiveness must be measured
- CDS override must be documented with reason

## 7. Patient Data Privacy

### 7.1 Consent Management
- Patient consent must be obtained before data sharing
- Consent must be specific (purpose-limited)
- Consent must be revocable
- Consent changes must be audited
- Emergency access override must be logged

### 7.2 Data Sharing
- Patient data shared only with explicit consent
- Data sharing agreements must be documented
- Third-party access must be logged
- Patient can request data deletion (right to be forgotten)

## 8. Clinical Audit

### 8.1 Audit Requirements
- Every patient data access must be logged
- Every clinical decision must be traceable
- Every result modification must be logged with before/after values
- Every QC failure must be logged with corrective action
- Every instrument issue must be logged with resolution

### 8.2 Audit Review
- Clinical audit logs reviewed monthly
- Incident reports reviewed by Clinical Board
- Quality indicator tracking and reporting
- Compliance with regulatory reporting requirements

## 9. Healthcare Compliance

### 9.1 Regulatory Compliance Target
| Regulation | Scope | Target |
|-----------|-------|--------|
| Iraqi Ministry of Health | Laboratory operations | Implemented |
| Iraqi Data Protection | Patient privacy | In progress |
| HIPAA (US, where applicable) | Patient data | Planned |
| GDPR (EU, where applicable) | Patient data | Planned |
| CLIA (US, where applicable) | Laboratory quality | Planned |
| ISO 15189 | Medical laboratory quality | Planned |

### 9.2 Quality Indicators
- Turnaround time per test
- Critical value notification time
- Sample rejection rate
- QC failure rate
- Accuracy in EQA programs
- Customer satisfaction score

## 10. Healthcare Domains

### 10.1 Current Coverage
| Domain | Maturity | Status |
|--------|----------|--------|
| Laboratory (LIMS) | 5.0/5.0 | Production |
| Clinical Terminology | 5.0/5.0 | Production |
| EHR / Patient Data | 4.5/5.0 | Production |
| Clinical Decision Support | 4.0/5.0 | Models + partial services |
| Radiology / PACS | 4.0/5.0 | Production |
| Pharmacy | 4.0/5.0 | Production |
| Blood Bank | 4.0/5.0 | Production |
| Nursing | 3.5/5.0 | Production |
| Critical Care | 3.5/5.0 | Production |
| Emergency Services | 3.5/5.0 | Production |
| Public Health | 3.5/5.0 | Production |
| Research | 4.0/5.0 | Production |
| Citizen Portal | 4.0/5.0 | Production |
| Hospital | 2.0/5.0 | Stub |
| National Health Data | 3.0/5.0 | In progress |

### 10.2 Required Healthcare Modules

Every healthcare module must follow the standard module structure with:
- Domain entities with clinical terminology mappings
- Repository interfaces for data access
- Event definitions for cross-domain communication
- FHIR resource mappings
- Health check endpoints
- Permission definitions
- Test coverage for clinical safety invariants

---

*This Healthcare Policy is mandatory. All exceptions require Clinical Board approval.*
